Olinvacimab With Pembrolizumab in Patients With mTNBC

Clinical trial NCT04986852 · TERMINATED

Trial details

NCT number: NCT04986852
Sponsor: PharmAbcine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Triple-Negative Breast Cancer

Start date: 2021-09-30
Primary completion: 2024-12-03
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.